Toll Free: 1-888-928-9744
Published: Sep, 2014 | Pages:
37 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Advenchen Laboratories, LLC - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Advenchen Laboratories, LLC - Product Pipeline Review - 2014', provides an overview of the Advenchen Laboratories, LLC's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Advenchen Laboratories, LLC's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Advenchen Laboratories, LLC including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Advenchen Laboratories, LLC's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Advenchen Laboratories, LLC's pipeline products Reasons to buy - Evaluate Advenchen Laboratories, LLC's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Advenchen Laboratories, LLC in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Advenchen Laboratories, LLC's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Advenchen Laboratories, LLC and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Advenchen Laboratories, LLC - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Advenchen Laboratories, LLC and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Advenchen Laboratories, LLC Snapshot 5 Advenchen Laboratories, LLC Overview 5 Key Information 5 Key Facts 5 Advenchen Laboratories, LLC - Research and Development Overview 6 Key Therapeutic Areas 6 Advenchen Laboratories, LLC - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Advenchen Laboratories, LLC - Pipeline Products Glance 11 Advenchen Laboratories, LLC - Late Stage Pipeline Products 11 Phase III Products/Combination Treatment Modalities 11 Advenchen Laboratories, LLC - Clinical Stage Pipeline Products 12 Phase II Products/Combination Treatment Modalities 12 Phase I Products/Combination Treatment Modalities 13 Advenchen Laboratories, LLC - Early Stage Pipeline Products 14 Preclinical Products/Combination Treatment Modalities 14 Advenchen Laboratories, LLC - Drug Profiles 15 YN-968D1 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 AL-3818 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 lucitanib 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 AL-6802 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 AL-2846 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 AL-8326 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 Advenchen Laboratories, LLC - Pipeline Analysis 26 Advenchen Laboratories, LLC - Pipeline Products by Target 26 Advenchen Laboratories, LLC - Pipeline Products by Route of Administration 28 Advenchen Laboratories, LLC - Pipeline Products by Molecule Type 29 Advenchen Laboratories, LLC - Pipeline Products by Mechanism of Action 30 Advenchen Laboratories, LLC - Recent Pipeline Updates 32 Advenchen Laboratories, LLC - Dormant Projects 34 Advenchen Laboratories, LLC - Locations And Subsidiaries 35 Head Office 35 Appendix 36 Methodology 36 Coverage 36 Secondary Research 36 Primary Research 36 Expert Panel Validation 36 Contact Us 37 Disclaimer 37
List of Tables Advenchen Laboratories, LLC, Key Information 5 Advenchen Laboratories, LLC, Key Facts 5 Advenchen Laboratories, LLC - Pipeline by Indication, 2014 8 Advenchen Laboratories, LLC - Pipeline by Stage of Development, 2014 9 Advenchen Laboratories, LLC - Monotherapy Products in Pipeline, 2014 10 Advenchen Laboratories, LLC - Phase III, 2014 11 Advenchen Laboratories, LLC - Phase II, 2014 12 Advenchen Laboratories, LLC - Phase I, 2014 13 Advenchen Laboratories, LLC - Preclinical, 2014 14 Advenchen Laboratories, LLC - Pipeline by Target, 2014 27 Advenchen Laboratories, LLC - Pipeline by Route of Administration, 2014 28 Advenchen Laboratories, LLC - Pipeline by Molecule Type, 2014 29 Advenchen Laboratories, LLC - Pipeline Products by Mechanism of Action, 2014 31 Advenchen Laboratories, LLC - Recent Pipeline Updates, 2014 32 Advenchen Laboratories, LLC - Dormant Developmental Projects,2014 34
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.